3 Stocks Worth Buying at 52-Week Lows

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad)

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Keurig Dr Pepper (KDP)	4.0869 of 5 stars	$33.85	+0.0%	2.54%	21.84	Moderate Buy	$36.45
Monster Beverage (MNST)	4.2469 of 5 stars	$53.21	+0.1%	N/A	34.33	Moderate Buy	$61.79
Pfizer (PFE)	4.9782 of 5 stars	$25.40	+0.6%	6.61%	70.56	Hold	$36.33
Seagen (SGEN)	0.3227 of 5 stars	$228.74	flat	N/A	-57.04	Hold	$229.00
Amgen (AMGN)	4.6783 of 5 stars	$270.19	+0.3%	3.33%	21.63	Moderate Buy	$296.95
Horizon Therapeutics Public (HZNP)	0 of 5 stars	$116.30	flat	N/A	62.19	Hold	N/A
CVS Health (CVS)	5 of 5 stars	$67.29	-0.1%	3.95%	10.42	Moderate Buy	$89.44